FOLH1 and prostate cancer: The human prostate cancer epithelial cell lines 22Rv1 (mild PSMA+) and PC-3 (with no PSMA receptor) were used to evaluate the specific cell-binding affinity of the radiotracers, and the results were expressed as percentages of injected activity, IA%/106.